Dorsey Wright & Associates’s AC Immune ACIU Stock Holding History

Dorsey Wright & Associates’s Portfolio ACIU Stock Details ACIU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1,324	Closed	-$9K	–	307
2020 Q1	$9K	Buy	+1,324	New	+$10.3K	﹤0.01%	152

Other funds holding ACIU

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Dorsey Wright & Associates's ACIU Position: Q2 2020 in Review

Dorsey Wright & Associates sold out of AC Immune (ACIU) in Q2 2020, closing a stake of 1,324 shares — an estimated $9K sold.

Dorsey Wright & Associates first reported a position in ACIU in Q1 2020 and held it in 1 quarter. The position peaked at $9K in Q1 2020. 42 funds tracked by Wall St. Rank hold ACIU as of Q2 2020.

Dorsey Wright & Associates reported no remaining AC Immune position as of Q2 2020 after selling out during the quarter.
Dorsey Wright & Associates sold 1,324 AC Immune shares in Q2 2020, an estimated $9K.
Dorsey Wright & Associates first reported a position in AC Immune in Q1 2020 and held it in 1 quarter.
Dorsey Wright & Associates's AC Immune position peaked at $9K in Q1 2020.
42 funds tracked by Wall St. Rank held AC Immune as of Q2 2020.

Based on Dorsey Wright & Associates's 13F filing for Q2 2020, filed 23 Jul 2020.